|4.||Hypertension (High Blood Pressure)
|5.||Bipolar Disorder (Mania)
|1.||Stárka, Luboslav: 2 articles (06/2013 - 12/2011)|
|2.||Zamrazil, Václav: 2 articles (06/2013 - 12/2011)|
|3.||Bílek, Radovan: 2 articles (06/2013 - 12/2011)|
|4.||Serdiuk, S E: 2 articles (01/2005 - 01/2004)|
|5.||Molashenko, N V: 2 articles (01/2005 - 01/2004)|
|6.||Platonova, N M: 2 articles (01/2005 - 01/2004)|
|7.||Sviridenko, N Iu: 2 articles (01/2005 - 01/2004)|
|8.||Golitsyn, S P: 2 articles (01/2005 - 01/2004)|
|9.||Bakalov, S A: 2 articles (01/2005 - 01/2004)|
|10.||Aragüés, José Maria: 1 article (12/2014)|
|1.||Amiodarone (Amiodarona)FDA LinkGeneric
11/01/1987 - "These observations indicate that amiodarone effectively blocks the suppressive effect of hyperthyroxinemia on TSH secretion, and that T3 is the mediator of thyroid feedback control in amiodarone treated patients."
01/01/2005 - "Amiodarone-associated hypothyroidism and euthyroid hyperthyroxinemia were not associated with loss of antiarrhythmic efficacy of amiodarone. "
12/01/1988 - "To further evaluate amiodarone-induced alterations of T4 metabolism, serum T4 transfer and distribution were evaluated by compartmental analysis of T4 kinetic studies from eight normal subjects receiving short-term amiodarone or an equivalent amount of iodide, five patients with selective hyperthyroxinemia induced by chronic amiodarone therapy (n = 4) or ioxithalamic acid (n = 1), and five with classical hyperthyroidism. "
12/01/1988 - "Previous studies indicate that increased serum total and free T4 levels may be secondary to a proportionally greater decrease in serum T4 clearance rates than in production rates after short-term amiodarone administration, to increased T4 production rates as well as reduced serum clearance rates in selective hyperthyroxinemia without overt hyperthyroidism following chronic amiodarone administration, and to a relatively greater increase in T4 production rates than in clearance rates in classical hyperthyroidism. "
09/01/2008 - "Marked hyperthyroxinemia during amiodarone treatment revealing thyroid hormone resistance syndrome."
|2.||Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
11/01/1995 - "The increased bioavailability of commercially available products, along with improved laboratory assays for measuring thyrotropin (TSH), has led to an increased chance of actual or detected iatrogenic hyperthyroxinemia. "
07/01/1987 - "Various disease states associated with euthyroid hyperthyroxinemia and inappropriate thyrotropin secretion are becoming increasingly recognized. "
07/01/1987 - "Euthyroid hyperthyroxinemia and inappropriate secretion of thyrotropin. "
04/01/2000 - "Euthyroid hyperthyroxinemia as a result of a transient increase in thyroid-stimulating hormone (TSH) levels may contribute to the development of manic disorder. "
01/01/1998 - "Thyrotropin (TSH)-secreting pituitary adenomas cause hyperthyroxinemia in the presence of "inappropriately" elevated concentrations of TSH. "
10/01/1987 - "In order to study the relationship of thyroid hormone to NK activity, a model for hyperthyroxinemia was induced in mice by addition of T4 to the drinking water. "
08/01/1997 - "Our results indicate that the sulfation of T4 may be related to the regulation of thyroid hormone metabolism in T4-treated subjects with relative hyperthyroxinemia."
04/01/1996 - "We thus conclude that the sulfation pathway may play a role in the homeostasis of thyroid hormone metabolism in T4-treated subjects with relative hyperthyroxinemia. "
11/01/1995 - "Significantly more patients had low (supersuppressed) TSH levels between 1982 and 1990 than between 1975 and 1981 (33 percent versus 10 percent; P = 0.02.) Excessive thyroid hormone replacement with iatrogenic hyperthyroxinemia is a common occurrence. "
01/01/1994 - "Resistance to thyroid hormone (RTH) is an uncommon inherited cause of hyperthyroxinemia with inappropriate TSH secretion. "
02/01/2014 - "Abnormal T4 binding to T4-binding prealbumin (TTR) is a rare cause of euthyroid hyperthyroxinemia, which is transmitted by autosomal dominant inheritance. "
02/05/1993 - "X-ray crystal structure of the Ala-109-->Thr variant of human transthyretin which produces euthyroid hyperthyroxinemia."
01/01/1992 - "A group of patients with prealbumin associated hyperthyroxinemia possess a common single base substitution in the fourth exon of their transthyretin gene. "
01/01/1989 - "We report the case of a multisecretory pancreatic endocrine tumour whose prealbumin secretion was so high that it produced a peak on routine serum protein electrophoresis and induced a euthyroid hyperthyroxinemia. "
01/01/1986 - "[Prealbumin-associated hyperthyroxinemia]."
|5.||Propranolol (Inderal)FDA LinkGeneric
11/01/1983 - "Propranolol-induced hyperthyroxinemia."
04/01/1983 - "Propranolol-induced hyperthyroxinemia."
12/01/1982 - "Hyperthyroxinemia in patients treated with high-dose propranolol."
01/01/1976 - "[Effect of propranolol on carbohydrate metabolism of the heart muscle in experimental hyperthyroxinemia]."
11/01/1983 - "This led us to study the prevalence of hyperthyroxinemia in 14 consecutively treated patients with hypertension on daily doses of propranolol of 320 mg or more. "
01/01/2014 - "Lithium-induced transient euthyroid hyperthyroxinemia: a case report."
11/01/1996 - "Euthyroid hyperthyroxinemia may be a benign, transient complication of lithium-therapy discontinuation and should be considered in the diagnostic evaluation of lithium-related thyroid abnormalities."
11/01/1996 - "We describe the case of a 16-year-old boy who developed transient hyperthyroxinemia after discontinuation of chronic lithium therapy. "
04/01/2000 - "The findings of the study lend support to the notion that euthyroid hyperthyroxinemia contributes to acute mania and suggest that lithium's short-term antimanic action may be mediated by its antithyroid effect."
10/01/1954 - "[Studies on iodine metabolism in hyperthyroidism without hyperthyroxinemia]."
09/19/1977 - "Release of thyroglobulin by follicular disruption probably resulted in hyperthyroxinemia and suppression of TSH and radioactive iodine uptake, as occurs in subacute thyroiditis."
09/01/1992 - "Hyperthyroxinemia with suppressed TSH developed within the first four weeks of IL-2 administration; during this phase, there was no technetium or iodine uptake by the thyroid gland. "
|8.||Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
|9.||Estrogens (Estrogen)FDA Link
01/01/1996 - "The purpose of our study was to assess the etiology of euthyroid hyperthyroxinemia not associated with estrogen use or pregnancy and to review the outcome of those erroneously treated. "
01/01/1996 - "The medical records of thirteen euthyroid patients with non estrogen associated hyperthyroxinemia were reviewed. "
01/01/1996 - "Etiology and outcome of non-estrogen associated hyperthyroxinemia in euthyroid patients at the San Juan City Hospital."
|10.||Thyroxine (Levothyroxine)FDA LinkGeneric
12/01/2011 - "Hyperthyroxinemia was found in 6.74% of all parallel sets of TSH and free thyroxine (FT4, n=259,590) values. "
06/01/2001 - "Among these are mutations responsible for hyperthyroxinemia, presenting high affinity for thyroxine (a TTR ligand). "
01/01/1992 - "As healthy heterozygous individuals have normal serum thyroxine concentrations, the hyperthyroxinemia sometimes found may not be primarily due to the variant."
01/01/1991 - "The euthyroid hyperthyroxinemia (EHT) is characterized on the one hand by a normal basal THS or TRH-TSH response but also by high plasma values of total thyroxine (TT4) on the other. "
01/01/1991 - "No statistically significant difference in response to antidepressant treatment was observed between the hyperthyroxinemia group and the normal serum thyroxine group."
06/07/1995 - "[Hyperthyroxinemia after parathyroidectomy. "